Virtus Fund Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Virtus Fund Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.42M	Buy	29,077 +19,575	+206%	+$990K	0.01%	267
2017 Q3	$513K	Sell	9,502 -591	-6%	-$34.7K	0.01%	284
2017 Q2	$590K	Sell	10,093 -301	-3%	-$12.1K	0.01%	297
2017 Q1	$407K	Sell	10,394 -10,025	-49%	-$319K	﹤0.01%	346
2016 Q4	$458K	Hold	20,419	–	–	﹤0.01%	342
2016 Q3	$464K	Hold	20,419	–	–	﹤0.01%	341
2016 Q2	$486K	Buy	20,419 +6,339	+45%	+$157K	﹤0.01%	343
2016 Q1	$287K	Sell	14,080 -3,049	-18%	-$96.7K	﹤0.01%	385
2015 Q4	$881K	Sell	17,129 -180	-1%	-$8.73K	0.01%	292
2015 Q3	$738K	Sell	17,309 -25,726	-60%	-$1.24M	0.01%	315
2015 Q2	$1.96M	Buy	+43,035	New	+$1.73M	0.01%	309
2014 Q3	–	Sell	-3,147	Closed	-$92K	–	2221
2014 Q2	$92K	Buy	+3,147	New	+$76.2K	﹤0.01%	1456

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Virtus Fund Advisers's PTLA Position: Q4 2017 in Review

Virtus Fund Advisers increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 206% in Q4 2017, buying an estimated $990K and bringing the position to 29,077 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #267.

Virtus Fund Advisers first reported a position in PTLA in Q2 2014 and has held it in 12 quarters since. The position peaked at $1.96M in Q2 2015. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

Virtus Fund Advisers held 29,077 shares of Portola Pharmaceuticals, Inc. worth $1.42M as of Q4 2017.
Virtus Fund Advisers bought 19,575 Portola Pharmaceuticals, Inc. shares in Q4 2017, an estimated $990K.
Portola Pharmaceuticals, Inc. made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #267 holding.
Virtus Fund Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and has held it in 12 quarters since.
Virtus Fund Advisers's Portola Pharmaceuticals, Inc. position peaked at $1.96M in Q2 2015.
215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.